Synovial sarcoma of the kidney

A clinicopathologic, immunohistochemical, and molecular genetic study of 16 cases

J. Kenneth Schoolmeester, John Cheville, Andrew L. Folpe

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We report the clinicopathologic and immunohistochemical features of 16 cases of genetically confirmed primary synovial sarcoma of the kidney. The cases occurred in 9 men and 7 women ranging in age from 17 to 78 years (mean, 46 y). The tumors were grossly large, solid, and variably cystic (2.2 to 19.0 cm; mean 8.6 cm). Microscopically, all tumors were of the monophasic type and diffusely immunoreactive for TLE1 and BCL-2. Focal pankeratin positivity was found in just under half. Ten cases carried an SS18-SSX2 fusion transcript, and 5 cases showed an SS18-SSX1 transcript by reverse transcription polymerase chain reaction. The remaining case demonstrated SS18 rearrangement by fluorescence in situ hybridization. Clinical follow-up information was available for 12 patients (range, 1 to 77 mo; mean, 32.5 mo). Fourteen patients underwent radical nephrectomy, and 3 patients had lung metastases at presentation. Six patients died of disease within 1 to 58 months (mean, 31 mo) of their diagnosis. Five patients were alive without evidence of disease 12 to 77 months (mean, 39 mos) after surgery. A single patient was alive with metastases to the spine 11 months after surgery. We conclude that renal synovial sarcoma is an aggressive tumor, with adverse patient outcome in >50% of cases. Synovial sarcoma must be distinguished from morphologically similar lesions of the kidney.

Original languageEnglish (US)
Pages (from-to)60-65
Number of pages6
JournalAmerican Journal of Surgical Pathology
Volume38
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Synovial Sarcoma
Molecular Biology
Kidney
Neoplasm Metastasis
Neoplasms
Nephrectomy
Fluorescence In Situ Hybridization
Reverse Transcription
Spine
Polymerase Chain Reaction
Lung

Keywords

  • immunohistochemistry
  • molecular genetics
  • renal neoplasms
  • synovial sarcoma

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery

Cite this

Synovial sarcoma of the kidney : A clinicopathologic, immunohistochemical, and molecular genetic study of 16 cases. / Schoolmeester, J. Kenneth; Cheville, John; Folpe, Andrew L.

In: American Journal of Surgical Pathology, Vol. 38, No. 1, 01.2014, p. 60-65.

Research output: Contribution to journalArticle

@article{4b4958058f2f4f759f6642edceda776b,
title = "Synovial sarcoma of the kidney: A clinicopathologic, immunohistochemical, and molecular genetic study of 16 cases",
abstract = "We report the clinicopathologic and immunohistochemical features of 16 cases of genetically confirmed primary synovial sarcoma of the kidney. The cases occurred in 9 men and 7 women ranging in age from 17 to 78 years (mean, 46 y). The tumors were grossly large, solid, and variably cystic (2.2 to 19.0 cm; mean 8.6 cm). Microscopically, all tumors were of the monophasic type and diffusely immunoreactive for TLE1 and BCL-2. Focal pankeratin positivity was found in just under half. Ten cases carried an SS18-SSX2 fusion transcript, and 5 cases showed an SS18-SSX1 transcript by reverse transcription polymerase chain reaction. The remaining case demonstrated SS18 rearrangement by fluorescence in situ hybridization. Clinical follow-up information was available for 12 patients (range, 1 to 77 mo; mean, 32.5 mo). Fourteen patients underwent radical nephrectomy, and 3 patients had lung metastases at presentation. Six patients died of disease within 1 to 58 months (mean, 31 mo) of their diagnosis. Five patients were alive without evidence of disease 12 to 77 months (mean, 39 mos) after surgery. A single patient was alive with metastases to the spine 11 months after surgery. We conclude that renal synovial sarcoma is an aggressive tumor, with adverse patient outcome in >50{\%} of cases. Synovial sarcoma must be distinguished from morphologically similar lesions of the kidney.",
keywords = "immunohistochemistry, molecular genetics, renal neoplasms, synovial sarcoma",
author = "Schoolmeester, {J. Kenneth} and John Cheville and Folpe, {Andrew L.}",
year = "2014",
month = "1",
doi = "10.1097/PAS.0b013e31829b2d0d",
language = "English (US)",
volume = "38",
pages = "60--65",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Synovial sarcoma of the kidney

T2 - A clinicopathologic, immunohistochemical, and molecular genetic study of 16 cases

AU - Schoolmeester, J. Kenneth

AU - Cheville, John

AU - Folpe, Andrew L.

PY - 2014/1

Y1 - 2014/1

N2 - We report the clinicopathologic and immunohistochemical features of 16 cases of genetically confirmed primary synovial sarcoma of the kidney. The cases occurred in 9 men and 7 women ranging in age from 17 to 78 years (mean, 46 y). The tumors were grossly large, solid, and variably cystic (2.2 to 19.0 cm; mean 8.6 cm). Microscopically, all tumors were of the monophasic type and diffusely immunoreactive for TLE1 and BCL-2. Focal pankeratin positivity was found in just under half. Ten cases carried an SS18-SSX2 fusion transcript, and 5 cases showed an SS18-SSX1 transcript by reverse transcription polymerase chain reaction. The remaining case demonstrated SS18 rearrangement by fluorescence in situ hybridization. Clinical follow-up information was available for 12 patients (range, 1 to 77 mo; mean, 32.5 mo). Fourteen patients underwent radical nephrectomy, and 3 patients had lung metastases at presentation. Six patients died of disease within 1 to 58 months (mean, 31 mo) of their diagnosis. Five patients were alive without evidence of disease 12 to 77 months (mean, 39 mos) after surgery. A single patient was alive with metastases to the spine 11 months after surgery. We conclude that renal synovial sarcoma is an aggressive tumor, with adverse patient outcome in >50% of cases. Synovial sarcoma must be distinguished from morphologically similar lesions of the kidney.

AB - We report the clinicopathologic and immunohistochemical features of 16 cases of genetically confirmed primary synovial sarcoma of the kidney. The cases occurred in 9 men and 7 women ranging in age from 17 to 78 years (mean, 46 y). The tumors were grossly large, solid, and variably cystic (2.2 to 19.0 cm; mean 8.6 cm). Microscopically, all tumors were of the monophasic type and diffusely immunoreactive for TLE1 and BCL-2. Focal pankeratin positivity was found in just under half. Ten cases carried an SS18-SSX2 fusion transcript, and 5 cases showed an SS18-SSX1 transcript by reverse transcription polymerase chain reaction. The remaining case demonstrated SS18 rearrangement by fluorescence in situ hybridization. Clinical follow-up information was available for 12 patients (range, 1 to 77 mo; mean, 32.5 mo). Fourteen patients underwent radical nephrectomy, and 3 patients had lung metastases at presentation. Six patients died of disease within 1 to 58 months (mean, 31 mo) of their diagnosis. Five patients were alive without evidence of disease 12 to 77 months (mean, 39 mos) after surgery. A single patient was alive with metastases to the spine 11 months after surgery. We conclude that renal synovial sarcoma is an aggressive tumor, with adverse patient outcome in >50% of cases. Synovial sarcoma must be distinguished from morphologically similar lesions of the kidney.

KW - immunohistochemistry

KW - molecular genetics

KW - renal neoplasms

KW - synovial sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84891628288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891628288&partnerID=8YFLogxK

U2 - 10.1097/PAS.0b013e31829b2d0d

DO - 10.1097/PAS.0b013e31829b2d0d

M3 - Article

VL - 38

SP - 60

EP - 65

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 1

ER -